This is a 72-year-old patient with multiple cardiovascular risk factors: a 15-year history of poorly controlled type 2 diabetes treated with oral antidiabetic agents, newly diagnosed hypertension managed with angiotensin-converting enzyme (ACE inhibitors) and amlodipine besylate, and a history of dyslipidemia, treated with statins. This evidence concerns the gene ACE and type 2 diabetes mellitus.